chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: couldn't make 2nd dose and it's been 45 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (couldn't make 2nd dose and it's been 45 days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (couldn't make 2nd dose and it's been 45 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (couldn't make 2nd dose and it's been 45 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported. No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: I got the shoot on the 8th of last month and I'm still very ill; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-Jun-2021 and was forwarded to the company on 03-Jun-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (I got the shoot on the 8th of last month and I'm still very ill) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (I got the shoot on the 8th of last month and I'm still very ill). At the time of the report, ILLNESS (I got the shoot on the 8th of last month and I'm still very ill) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.  Concomitant product use was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (today she is in bad pain) and PYREXIA (today she has a fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 02-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jun-2021, the patient experienced PAIN (today she is in bad pain) and PYREXIA (today she has a fever). At the time of the report, PAIN (today she is in bad pain) and PYREXIA (today she has a fever) outcome was unknown.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. Treatment details were not reported. Reporter did not allow further contact.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus, Swelling
Clinical narrative: swelling; itching; swollen lines; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling), PRURITUS (itching) and PERIPHERAL SWELLING (swollen lines) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 03-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jun-2021, the patient experienced SWELLING (swelling), PRURITUS (itching) and PERIPHERAL SWELLING (swollen lines). The patient was treated with IBUPROFEN at a dose of UNK dosage form. At the time of the report, SWELLING (swelling), PRURITUS (itching) and PERIPHERAL SWELLING (swollen lines) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included Asthma Inhaler. Following the administration of vaccine, the patient had been experiencing, on her left hand, some itching, swelling and a couple of random lines that are extra swollen on top of the area. It looked like a bug bite. This was between the thumb and pointer finger. The patient believed this area was slowly growing and was still present at the time of reporting. This reaction occurred on the same arm of the injection.
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Feeling hot
Clinical narrative: now I have 2inch mild red wring; that is warm to the touch where I got the shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (now I have 2inch mild red wring) and FEELING HOT (that is warm to the touch where I got the shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (now I have 2inch mild red wring) and FEELING HOT (that is warm to the touch where I got the shot). At the time of the report, ERYTHEMA (now I have 2inch mild red wring) and FEELING HOT (that is warm to the touch where I got the shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Asthma
Clinical narrative: Asthma; This spontaneous case was reported by a consumer and describes the occurrence of ASTHMA (Asthma) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHMA (Asthma). At the time of the report, ASTHMA (Asthma) outcome was unknown.            No concomitant medications provided. No treatment details were reported.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Side effects last 4 to 5 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects last 4 to 5 days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects last 4 to 5 days). At the time of the report, VACCINATION COMPLICATION (Side effects last 4 to 5 days) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Intentional product use issue
Clinical narrative: impossible take The other dosis; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-May-2021 and was forwarded to Moderna on 03-Jun-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (impossible take The other dosis) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (impossible take The other dosis). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (impossible take The other dosis) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were reported. No treatment was reported.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, COVID-19, Condition aggravated, Influenza, Urine analysis
Clinical narrative: Worst flu of his life without cough and runny nose; symptoms seems to be getting worse as the weeks pass; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INFLUENZA (Worst flu of his life without cough and runny nose) and CONDITION AGGRAVATED (symptoms seems to be getting worse as the weeks pass) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, the patient experienced INFLUENZA (Worst flu of his life without cough and runny nose) and CONDITION AGGRAVATED (symptoms seems to be getting worse as the weeks pass). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, INFLUENZA (Worst flu of his life without cough and runny nose) outcome was unknown and CONDITION AGGRAVATED (symptoms seems to be getting worse as the weeks pass) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-May-2021, Blood test: normal (normal) Other. On 17-May-2021, COVID-19: negative (Negative) Other. On 17-May-2021, Urine analysis: normal (normal) Other.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information also included: Cold meds (name unavailable).
Sex: U
Vaccine: COVID19
Symptoms: Allergy to vaccine
Clinical narrative: Allergic to that one chemical present in moderna vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (Allergic to that one chemical present in moderna vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to chemicals (Polyethylene glycol).    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ALLERGY TO VACCINE (Allergic to that one chemical present in moderna vaccine). At the time of the report, ALLERGY TO VACCINE (Allergic to that one chemical present in moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: ¨still has severe pain¨; ¨Headache¨; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (¨still has severe pain¨) and HEADACHE (¨Headache¨) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jun-2021, the patient experienced MYALGIA (¨still has severe pain¨) and HEADACHE (¨Headache¨). At the time of the report, MYALGIA (¨still has severe pain¨) and HEADACHE (¨Headache¨) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided by reporter. Treatment information was not provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chills, Dizziness, Headache
Clinical narrative: Pinched Nerve entire Left Arm (After Second Vaccine); Entire left arm was in Pain; Headache; Rash left side of back and Shoulder-blade; Bad chills; Fever; Itching left side of back and Shoulder-blade; Throat Hurt; Dizziness; Felt weak; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching left side of back and Shoulder-blade), OROPHARYNGEAL PAIN (Throat Hurt), DIZZINESS (Dizziness), ASTHENIA (Felt weak) and NEURALGIA (Pinched Nerve entire Left Arm (After Second Vaccine)) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Apr-2021, the patient experienced PRURITUS (Itching left side of back and Shoulder-blade), OROPHARYNGEAL PAIN (Throat Hurt), DIZZINESS (Dizziness), ASTHENIA (Felt weak), RASH (Rash left side of back and Shoulder-blade), CHILLS (Bad chills), PYREXIA (Fever) and HEADACHE (Headache). On 30-Apr-2021, the patient experienced NEURALGIA (Pinched Nerve entire Left Arm (After Second Vaccine)) and MYALGIA (Entire left arm was in Pain). On 29-Apr-2021, OROPHARYNGEAL PAIN (Throat Hurt), CHILLS (Bad chills), PYREXIA (Fever) and HEADACHE (Headache) had resolved. On 03-May-2021, PRURITUS (Itching left side of back and Shoulder-blade), DIZZINESS (Dizziness), ASTHENIA (Felt weak) and RASH (Rash left side of back and Shoulder-blade) had resolved. On 06-May-2021, NEURALGIA (Pinched Nerve entire Left Arm (After Second Vaccine)) and MYALGIA (Entire left arm was in Pain) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) 101F.         Patient's rash was the size of a baseball. Patient's family physician told her that the arm pain might be from a pinched nerve.  Action taken with mRNA-1273 in response to the event was not applicable  No relevant concomitant medications were reported.  No treatment information was provided.       Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Followup received on 04-Jun-2021; Added date for dose 1. Added new events Pruritis, Oropharyngeal pain, Dizziness, Asthenia, Pyrexia, neuralgia , Myalgia and Headache. Updated product information and date for dose 2. Updated start and stop dates of events Chills and Rash. Updated product-event details.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Neuralgia, Oropharyngeal pain, Pruritus, Pyrexia
Clinical narrative: Pinched Nerve entire Left Arm (After Second Vaccine); Entire left arm was in Pain; Headache; Rash left side of back and Shoulder-blade; Bad chills; Fever; Itching left side of back and Shoulder-blade; Throat Hurt; Dizziness; Felt weak; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching left side of back and Shoulder-blade), OROPHARYNGEAL PAIN (Throat Hurt), DIZZINESS (Dizziness), ASTHENIA (Felt weak) and NEURALGIA (Pinched Nerve entire Left Arm (After Second Vaccine)) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Apr-2021, the patient experienced PRURITUS (Itching left side of back and Shoulder-blade), OROPHARYNGEAL PAIN (Throat Hurt), DIZZINESS (Dizziness), ASTHENIA (Felt weak), RASH (Rash left side of back and Shoulder-blade), CHILLS (Bad chills), PYREXIA (Fever) and HEADACHE (Headache). On 30-Apr-2021, the patient experienced NEURALGIA (Pinched Nerve entire Left Arm (After Second Vaccine)) and MYALGIA (Entire left arm was in Pain). On 29-Apr-2021, OROPHARYNGEAL PAIN (Throat Hurt), CHILLS (Bad chills), PYREXIA (Fever) and HEADACHE (Headache) had resolved. On 03-May-2021, PRURITUS (Itching left side of back and Shoulder-blade), DIZZINESS (Dizziness), ASTHENIA (Felt weak) and RASH (Rash left side of back and Shoulder-blade) had resolved. On 06-May-2021, NEURALGIA (Pinched Nerve entire Left Arm (After Second Vaccine)) and MYALGIA (Entire left arm was in Pain) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) 101F.         Patient's rash was the size of a baseball. Patient's family physician told her that the arm pain might be from a pinched nerve.  Action taken with mRNA-1273 in response to the event was not applicable  No relevant concomitant medications were reported.  No treatment information was provided.       Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Followup received on 04-Jun-2021; Added date for dose 1. Added new events Pruritis, Oropharyngeal pain, Dizziness, Asthenia, Pyrexia, neuralgia , Myalgia and Headache. Updated product information and date for dose 2. Updated start and stop dates of events Chills and Rash. Updated product-event details.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Pinched Nerve entire Left Arm (After Second Vaccine); Entire left arm was in Pain; Headache; Rash left side of back and Shoulder-blade; Bad chills; Fever; Itching left side of back and Shoulder-blade; Throat Hurt; Dizziness; Felt weak; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching left side of back and Shoulder-blade), OROPHARYNGEAL PAIN (Throat Hurt), DIZZINESS (Dizziness), ASTHENIA (Felt weak) and NEURALGIA (Pinched Nerve entire Left Arm (After Second Vaccine)) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Apr-2021, the patient experienced PRURITUS (Itching left side of back and Shoulder-blade), OROPHARYNGEAL PAIN (Throat Hurt), DIZZINESS (Dizziness), ASTHENIA (Felt weak), RASH (Rash left side of back and Shoulder-blade), CHILLS (Bad chills), PYREXIA (Fever) and HEADACHE (Headache). On 30-Apr-2021, the patient experienced NEURALGIA (Pinched Nerve entire Left Arm (After Second Vaccine)) and MYALGIA (Entire left arm was in Pain). On 29-Apr-2021, OROPHARYNGEAL PAIN (Throat Hurt), CHILLS (Bad chills), PYREXIA (Fever) and HEADACHE (Headache) had resolved. On 03-May-2021, PRURITUS (Itching left side of back and Shoulder-blade), DIZZINESS (Dizziness), ASTHENIA (Felt weak) and RASH (Rash left side of back and Shoulder-blade) had resolved. On 06-May-2021, NEURALGIA (Pinched Nerve entire Left Arm (After Second Vaccine)) and MYALGIA (Entire left arm was in Pain) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) 101F.         Patient's rash was the size of a baseball. Patient's family physician told her that the arm pain might be from a pinched nerve.  Action taken with mRNA-1273 in response to the event was not applicable  No relevant concomitant medications were reported.  No treatment information was provided.       Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Followup received on 04-Jun-2021; Added date for dose 1. Added new events Pruritis, Oropharyngeal pain, Dizziness, Asthenia, Pyrexia, neuralgia , Myalgia and Headache. Updated product information and date for dose 2. Updated start and stop dates of events Chills and Rash. Updated product-event details.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: spot is red now; spot is itchy; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (spot is red now) and VACCINATION SITE PRURITUS (spot is itchy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (spot is red now) and VACCINATION SITE PRURITUS (spot is itchy). At the time of the report, VACCINATION SITE ERYTHEMA (spot is red now) and VACCINATION SITE PRURITUS (spot is itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product details was not reported.  Treatment details was not reported .  Post vaccination of 7 days patient experienced red and itchiness at injection site.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Fatigue, Gait disturbance
Clinical narrative: had a shooting pain in arm; felt like getting temperature; severe headache; chills, hot and cold chills; shivering; Nauseous; joint pain; wiped out totally tired; Perspiring; dizziness; Arm was shaky; hot flashes; need to be careful when walk; shook her body; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Mar-2021. The most recent information was received on 07-Jun-2021 and was forwarded to Moderna on 07-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Perspiring), DIZZINESS (dizziness), NERVOUSNESS (Arm was shaky), HOT FLUSH (hot flashes) and GAIT DISTURBANCE (need to be careful when walk) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced HYPERHIDROSIS (Perspiring). 08-Mar-2021, the patient experienced DIZZINESS (dizziness), NERVOUSNESS (Arm was shaky), GAIT DISTURBANCE (need to be careful when walk), TREMOR (shook her body), HEADACHE (severe headache), CHILLS (chills, hot and cold chills), CHILLS (shivering), NAUSEA (Nauseous) and ARTHRALGIA (joint pain). 08-Mar-2021, the patient experienced HOT FLUSH (hot flashes), PYREXIA (felt like getting temperature) and FATIGUE (wiped out totally tired). On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (had a shooting pain in arm). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 250 mg and FEXOFENADINE on 10-Mar-2021 at a dose of 1 dosage form, 1 dose. On 10-Mar-2021, PAIN IN EXTREMITY (had a shooting pain in arm) had resolved. On 11-Mar-2021, HEADACHE (severe headache) had resolved. At the time of the report, HYPERHIDROSIS (Perspiring), DIZZINESS (dizziness), NERVOUSNESS (Arm was shaky), HOT FLUSH (hot flashes), GAIT DISTURBANCE (need to be careful when walk), TREMOR (shook her body), PYREXIA (felt like getting temperature), CHILLS (chills, hot and cold chills), NAUSEA (Nauseous), ARTHRALGIA (joint pain) and FATIGUE (wiped out totally tired) outcome was unknown and CHILLS (shivering) had resolved.      No treatment information or concomitant medications were provided by reporter.  Action taken with the drug in response to the events was not provided by the Reporter.  Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: significant follow up accepted on 08-06-2021
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hot flush, Hyperhidrosis, Nausea, Nervousness
Clinical narrative: had a shooting pain in arm; felt like getting temperature; severe headache; chills, hot and cold chills; shivering; Nauseous; joint pain; wiped out totally tired; Perspiring; dizziness; Arm was shaky; hot flashes; need to be careful when walk; shook her body; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Mar-2021. The most recent information was received on 07-Jun-2021 and was forwarded to Moderna on 07-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Perspiring), DIZZINESS (dizziness), NERVOUSNESS (Arm was shaky), HOT FLUSH (hot flashes) and GAIT DISTURBANCE (need to be careful when walk) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced HYPERHIDROSIS (Perspiring). 08-Mar-2021, the patient experienced DIZZINESS (dizziness), NERVOUSNESS (Arm was shaky), GAIT DISTURBANCE (need to be careful when walk), TREMOR (shook her body), HEADACHE (severe headache), CHILLS (chills, hot and cold chills), CHILLS (shivering), NAUSEA (Nauseous) and ARTHRALGIA (joint pain). 08-Mar-2021, the patient experienced HOT FLUSH (hot flashes), PYREXIA (felt like getting temperature) and FATIGUE (wiped out totally tired). On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (had a shooting pain in arm). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 250 mg and FEXOFENADINE on 10-Mar-2021 at a dose of 1 dosage form, 1 dose. On 10-Mar-2021, PAIN IN EXTREMITY (had a shooting pain in arm) had resolved. On 11-Mar-2021, HEADACHE (severe headache) had resolved. At the time of the report, HYPERHIDROSIS (Perspiring), DIZZINESS (dizziness), NERVOUSNESS (Arm was shaky), HOT FLUSH (hot flashes), GAIT DISTURBANCE (need to be careful when walk), TREMOR (shook her body), PYREXIA (felt like getting temperature), CHILLS (chills, hot and cold chills), NAUSEA (Nauseous), ARTHRALGIA (joint pain) and FATIGUE (wiped out totally tired) outcome was unknown and CHILLS (shivering) had resolved.      No treatment information or concomitant medications were provided by reporter.  Action taken with the drug in response to the events was not provided by the Reporter.  Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: significant follow up accepted on 08-06-2021
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Tremor
Clinical narrative: had a shooting pain in arm; felt like getting temperature; severe headache; chills, hot and cold chills; shivering; Nauseous; joint pain; wiped out totally tired; Perspiring; dizziness; Arm was shaky; hot flashes; need to be careful when walk; shook her body; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Mar-2021. The most recent information was received on 07-Jun-2021 and was forwarded to Moderna on 07-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Perspiring), DIZZINESS (dizziness), NERVOUSNESS (Arm was shaky), HOT FLUSH (hot flashes) and GAIT DISTURBANCE (need to be careful when walk) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced HYPERHIDROSIS (Perspiring). 08-Mar-2021, the patient experienced DIZZINESS (dizziness), NERVOUSNESS (Arm was shaky), GAIT DISTURBANCE (need to be careful when walk), TREMOR (shook her body), HEADACHE (severe headache), CHILLS (chills, hot and cold chills), CHILLS (shivering), NAUSEA (Nauseous) and ARTHRALGIA (joint pain). 08-Mar-2021, the patient experienced HOT FLUSH (hot flashes), PYREXIA (felt like getting temperature) and FATIGUE (wiped out totally tired). On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (had a shooting pain in arm). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 250 mg and FEXOFENADINE on 10-Mar-2021 at a dose of 1 dosage form, 1 dose. On 10-Mar-2021, PAIN IN EXTREMITY (had a shooting pain in arm) had resolved. On 11-Mar-2021, HEADACHE (severe headache) had resolved. At the time of the report, HYPERHIDROSIS (Perspiring), DIZZINESS (dizziness), NERVOUSNESS (Arm was shaky), HOT FLUSH (hot flashes), GAIT DISTURBANCE (need to be careful when walk), TREMOR (shook her body), PYREXIA (felt like getting temperature), CHILLS (chills, hot and cold chills), NAUSEA (Nauseous), ARTHRALGIA (joint pain) and FATIGUE (wiped out totally tired) outcome was unknown and CHILLS (shivering) had resolved.      No treatment information or concomitant medications were provided by reporter.  Action taken with the drug in response to the events was not provided by the Reporter.  Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: significant follow up accepted on 08-06-2021
Sex: U
Vaccine: COVID19
Symptoms: Allergy to vaccine
Clinical narrative: allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (allergic reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ALLERGY TO VACCINE (allergic reaction). At the time of the report, ALLERGY TO VACCINE (allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication were not reported  Concomitant medication were not reported
Sex: U
Vaccine: COVID19
Symptoms: Insomnia, Rhinorrhoea, Sinusitis
Clinical narrative: excess mucous; sinis infection; can hardly sleep; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHEA (excess mucous), SINUSITIS (sinis infection) and INSOMNIA (can hardly sleep) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHINORRHEA (excess mucous), SINUSITIS (sinis infection) and INSOMNIA (can hardly sleep). At the time of the report, RHINORRHEA (excess mucous), SINUSITIS (sinis infection) and INSOMNIA (can hardly sleep) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not provided by the reporter. Treatment medication were not provided by the reporter.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: ¨still has severe pain¨; ¨Headache¨; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (¨still has severe pain¨) and HEADACHE (¨Headache¨) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: COVID-19 VACCINE MODERNA.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jun-2021, the patient experienced MYALGIA (¨still has severe pain¨) and HEADACHE (¨Headache¨). At the time of the report, MYALGIA (¨still has severe pain¨) and HEADACHE (¨Headache¨) outcome was unknown.            No Concomitant medication were provided by reporter.  No Treatment information was reported.   This case was linked to MOD-2021-207508 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site mass
Clinical narrative: I have a big lump at the injection spot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE MASS (Vaccination site lump) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Vaccination site lump). At the time of the report, VACCINATION SITE MASS (Vaccination site lump) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided   Reporter did not allow further contact
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood test, Fatigue
Clinical narrative: Severe fatigue; Weakness; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of FATIGUE (Severe fatigue) and ASTHENIA (Weakness) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Severe fatigue) and ASTHENIA (Weakness). At the time of the report, FATIGUE (Severe fatigue) and ASTHENIA (Weakness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information was provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), was not applicable.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea, Urticaria
Clinical narrative: Severe diarrhoea; I still experience hives on my back, on right shoulder; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Severe diarrhoea), URTICARIA (I still experience hives on my back, on right shoulder) and NAUSEA (Nausea) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     The patient's past medical history included Cancer (The patient was cancer survivor.).    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Severe diarrhoea), URTICARIA (I still experience hives on my back, on right shoulder) and NAUSEA (Nausea). At the time of the report, DIARRHOEA (Severe diarrhoea) and NAUSEA (Nausea) had resolved and URTICARIA (I still experience hives on my back, on right shoulder) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs was provided.  No treatment drugs was provided.  The patient stated she had poor immune system.  And the patient also stated that she  was vaccinated with 2nd dose and was still experiencing hives on her back  which was the  event after  first dose.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Fatigue, Inappropriate affect, Malaise, Nausea
Clinical narrative: Felt like million dollar; patient is feeling bad, not feeling good; stomach bothering a little; Nausea; tired; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE AFFECT (Felt like million dollar), MALAISE (patient is feeling bad, not feeling good), ABDOMINAL DISCOMFORT (stomach bothering a little), NAUSEA (Nausea) and FATIGUE (tired) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030C214) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Medical history information reported.). Concomitant products included VITAMINS NOS (DAILY VITAMINS) for an unknown indication.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE AFFECT (Felt like million dollar), MALAISE (patient is feeling bad, not feeling good), ABDOMINAL DISCOMFORT (stomach bothering a little), NAUSEA (Nausea) and FATIGUE (tired). At the time of the report, INAPPROPRIATE AFFECT (Felt like million dollar), MALAISE (patient is feeling bad, not feeling good), ABDOMINAL DISCOMFORT (stomach bothering a little), NAUSEA (Nausea) and FATIGUE (tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient had three Heart pills, a Thyroid medication and an indigestion tablet as Concomitant medication.  Action taken with mRNA-1273 in response to the events was Not Applicable   This case was linked to MOD-2021-208275, MOD-2021-208275 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: No specific follow-up information recorded.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported. No Treatment information was reported.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Rhinorrhoea, Sinusitis
Clinical narrative: sinis infection; excess mucous; can hardly sleep because of the mucous; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (sinis infection), RHINORRHOEA (excess mucous) and INSOMNIA (can hardly sleep because of the mucous) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SINUSITIS (sinis infection), RHINORRHOEA (excess mucous) and INSOMNIA (can hardly sleep because of the mucous). At the time of the report, SINUSITIS (sinis infection), RHINORRHOEA (excess mucous) and INSOMNIA (can hardly sleep because of the mucous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medications were not reported.  The treatment information was  not provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Follow up document was received and no new information was reported.
Sex: U
Vaccine: COVID19
Symptoms: Allergy to vaccine
Clinical narrative: I caught an allergic reaction when I got my first vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (I caught an allergic reaction when I got my first vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALLERGY TO VACCINE (I caught an allergic reaction when I got my first vaccine). At the time of the report, ALLERGY TO VACCINE (I caught an allergic reaction when I got my first vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Chills, Headache, Oropharyngeal pain, Pyrexia
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (Fever), CHILLS (Chills), OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), CHILLS (Chills), OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headache). At the time of the report, PYREXIA (Fever), CHILLS (Chills), OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headache) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications reported. No treatment information was provided. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal discomfort, Vaccination site mass
Clinical narrative: lump at injection site from first vaccine has not gone away; physically can't move his shoulder to the up position; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (lump at injection site from first vaccine has not gone away) and MUSCULOSKELETAL DISCOMFORT (physically can't move his shoulder to the up position) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007C21A and 035C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-May-2021, the patient experienced VACCINATION SITE MASS (lump at injection site from first vaccine has not gone away) and MUSCULOSKELETAL DISCOMFORT (physically can't move his shoulder to the up position). At the time of the report, VACCINATION SITE MASS (lump at injection site from first vaccine has not gone away) and MUSCULOSKELETAL DISCOMFORT (physically can't move his shoulder to the up position) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: How long do i have to wait to take otc pain meds after vaccine.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (How long do i have to wait to take otc pain meds after vaccine.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (How long do i have to wait to take otc pain meds after vaccine.). At the time of the report, VACCINATION COMPLICATION (How long do i have to wait to take otc pain meds after vaccine.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Chills, Discomfort, Myalgia, Pyrexia
Clinical narrative: We feel like truck ran over us!!; No energy,I'm too weak to drive; Chills; Fever; Body aches; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (We feel like truck ran over us!!), ASTHENIA (No energy,I'm too weak to drive), CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Body aches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (We feel like truck ran over us!!), ASTHENIA (No energy,I'm too weak to drive), CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Body aches). At the time of the report, DISCOMFORT (We feel like truck ran over us!!), ASTHENIA (No energy,I'm too weak to drive), CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product was not provided by the reporter.  Treatment information was not provided.    Reporter did not allow further contact